Drug-Induced and Iatrogenic Diabetic Gastroparesis Known causes of iatrogenic gastroparesis include vagal inhibition due to vagal injury after fundoplication for gastroesophageal reflux disease and prescription medications that affect gastric emptying (Table 4)
Thyroxine can also assist in the upregulation of the CPT1A gene by increasing PGC-1 mRNA and protein levels in hepatocytes (Zhang et al., 2004)
Hantering av viktminskning GLP-1 Advanced Metabolic saktar ner magtmningen och frmjar mttnadsknsla, vilket minskar aptiten och matintaget, vilket kan leda till lgre kaloriintag och kad fettfrbrnning
The dosing rules are strict because absorption is limited
These findings support the safety and potential disease-modifying effects of FUS-mediated BBB opening in early-stage AD, although larger trials are warranted to establish clinical efficacy (Rezai et al., 2024)
People who carry the genetic mutations that cause G6PD deficiency are at an increased risk for hemolytic anemia when taking certain medications, including quinine-based medication